Presence of Genetic Variants Among Young Men With Severe COVID-19.
暂无分享,去创建一个
J. Schuurs-Hoeijmakers | A. Hoischen | M. Jaeger | L. Joosten | M. Netea | M. Nelen | H. Brunner | C. Gilissen | J. V. D. van der Meer | M. Steehouwer | A. Simons | H. Yntema | Q. de Mast | F. L. van de Veerdonk | T. Mantere | H. van der Hoeven | C. Bleeker‐Rovers | Simon V. van Reijmersdal | E. Klijn | S. V. van Reijmersdal | Jordi Corominas Galbany | G. Astuti | V. van der Schoot | C. I. van der Made | R. V. van Deuren | W. Hagmolen of ten Have | T. Hofste | Caspar I. van der Made | Simone Kersten | G. van den Heuvel | Catrien van den Meer | Jeroen Fiddelaers | Vyne van der Schoot | Tuomo Mantere
[1] Nicolas Carlier,et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.
[2] Michael Klompas,et al. Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence. , 2020, JAMA.
[3] J. Izopet,et al. TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women. , 2020, JCI insight.
[4] J. Erdmann,et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure , 2020, The New England journal of medicine.
[5] Manfred S. Green,et al. The male excess in case-fatality rates for COVID-19. A meta-analytic study of the age-related differences and consistency over six countries , 2020, medRxiv.
[6] S. Klein,et al. Considering how biological sex impacts immune responses and COVID-19 outcomes , 2020, Nature Reviews Immunology.
[7] D. Acharya,et al. Dysregulation of type I interferon responses in COVID-19 , 2020, Nature Reviews Immunology.
[8] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[9] Kwok-Hung Chan,et al. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial , 2020, The Lancet.
[10] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[11] M. Moreno-Eutimio,et al. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes , 2020, Microbes and Infection.
[12] M. Tay,et al. The trinity of COVID-19: immunity, inflammation and intervention , 2020, Nature Reviews Immunology.
[13] L. Vissers,et al. Rapid whole exome sequencing in pregnancies to identify the underlying genetic cause in fetuses with congenital anomalies detected by ultrasound imaging , 2020, Prenatal diagnosis.
[14] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[15] L. Piemonti,et al. Gender and Age Effects on the Rates of Infection and Deaths in Individuals with Confirmed SARS-CoV-2 Infection in Six European Countries , 2020 .
[16] S. Merler,et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.
[17] C. Eastin,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.
[18] J. Casanova,et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification , 2020, Journal of Clinical Immunology.
[19] Patrick J. Short,et al. Integrating healthcare and research genetic data empowers the discovery of 49 novel developmental disorders , 2019, bioRxiv.
[20] David K. Meyerholz,et al. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. , 2019, The Journal of clinical investigation.
[21] J. Schuurs-Hoeijmakers,et al. Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies , 2019, Genome Medicine.
[22] D. Brooks,et al. Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice , 2019, Scientific Reports.
[23] J. E. Mejía,et al. Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation , 2018, Seminars in Immunopathology.
[24] M. Ait-goughoulte,et al. TLR7 polymorphism, sex and chronic HBV infection influence plasmacytoid DC maturation by TLR7 ligands , 2018, Antiviral research.
[25] A. Canivet,et al. TLR7 escapes X chromosome inactivation in immune cells , 2018, Science Immunology.
[26] J. Casanova,et al. Human genetics of infectious diseases: Unique insights into immunological redundancy. , 2017, Seminars in immunology.
[27] C. Halldén,et al. Genetic variation of the Toll-like receptors in a Swedish allergic rhinitis case population , 2017, BMC Medical Genetics.
[28] R. Xavier,et al. Functional and Genomic Architecture of Borrelia burgdorferi-Induced Cytokine Responses in Humans. , 2016, Cell host & microbe.
[29] L. Vissers,et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.
[30] D. Falzarano,et al. SARS and MERS: recent insights into emerging coronaviruses , 2016, Nature Reviews Microbiology.
[31] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[32] Jeung-Hoon Lee,et al. Roles of TLR7 in Activation of NF-κB Signaling of Keratinocytes by Imiquimod , 2013, PloS one.
[33] M. Przeworski,et al. Different selective pressures shape the evolution of Toll-like receptors in human and African great ape populations. , 2013, Human molecular genetics.
[34] J. Casanova,et al. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. , 2011, Annual review of immunology.
[35] Christian Gilissen,et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome , 2010, Nature Genetics.
[36] M. Altfeld,et al. Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1 , 2009, Nature Medicine.
[37] H. Jessen,et al. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression , 2009, AIDS.
[38] A. Smahi,et al. TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.
[39] S. Akira,et al. Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon , 2007, Blood.
[40] J. Casanova,et al. Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency , 2006, Science.